DrugPatentWatch Database Updates: New Patent Delistings
✉ Email this page to a colleague
DrugPatentWatch Database Updates: New Patent Delistings
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Usecode | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE | 210496 | Jun 27, 2018 | DISCN | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE | 210496 | Jun 27, 2018 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Neurocrine | ONGENTYS | opicapone | CAPSULE | 212489 | Apr 24, 2020 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | U-2812 | ADJUNCTIVE TREATMENT TO LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSON'S DISEASE |
Gilead Sciences Inc | VEKLURY | remdesivir | SOLUTION | 214787 | Oct 22, 2020 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Gilead Sciences Inc | VEKLURY | remdesivir | SOLUTION | 214787 | Oct 22, 2020 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Gilead Sciences Inc | VEKLURY | remdesivir | SOLUTION | 214787 | Oct 22, 2020 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | U-2984 | TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19) IN ADULTS AND PEDIATRIC PATIENTS (AT LEAST 12 YEARS OF AGE AND 40 KG) REQUIRING HOSPITALIZATION |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |